Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-02-09 Sale |
2024-02-12 7:25 pm |
JOHNSON & JOHNSON | JNJ | Taubert Jennifer L EVP, WW Chair, Pharmaceuticals |
59,397 | $156.27 | $9,281,969 | 141,416 (Direct) |
View |
| 2023-08-23 Sale |
2023-08-25 4:07 pm |
JOHNSON & JOHNSON | JNJ | Hait William See Remarks |
696 | $0 | $0 | 87,051 (Direct) |
View |
| 2023-08-23 Sale |
2023-08-25 4:07 pm |
JOHNSON & JOHNSON | JNJ | McEvoy Ashley EVP, WW Chair, MedTech |
2,787 | $0 | $0 | 55,144 (Indirect Direct) |
View |
| 2023-08-23 Sale |
2023-08-25 4:07 pm |
JOHNSON & JOHNSON | JNJ | Fasolo Peter Exec VP, Chief HR Officer |
232 | $0 | $0 | 102,464 (Direct) |
View |
| 2023-08-23 Sale |
2023-08-25 4:07 pm |
JOHNSON & JOHNSON | JNJ | Duato Joaquin CEO and Chairman of the Board |
11,035 | $0 | $0 | 306,217 (Indirect Direct) |
View |
| 2023-08-23 Sale |
2023-08-25 4:07 pm |
JOHNSON & JOHNSON | JNJ | Wolk Joseph J Exec VP, CFO |
67 | $0 | $0 | 52,293 (Indirect Direct) |
View |
| 2023-07-25 Sale |
2023-07-27 5:52 pm |
JOHNSON & JOHNSON | JNJ | Fasolo Peter Exec VP, Chief HR Officer |
20,000 | $170.32 | $3,406,498 | 102,696 (Direct) |
View |
| 2023-07-26 Sale |
2023-07-27 5:52 pm |
JOHNSON & JOHNSON | JNJ | Hait William See Remarks |
14,698 | $172 | $2,528,056 | 87,747 (Direct) |
View |
| 2023-06-12 Sale |
2023-06-14 4:19 pm |
JOHNSON & JOHNSON | JNJ | Wengel Kathryn E EVP, Chief TO and Risk Officer |
12,465 | $160 | $1,994,400 | 66,274 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-02-09 Exercise |
2024-02-12 7:25 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Taubert Jennifer L EVP, WW Chair, Pharmaceuticals |
59,397 | $90.44 | 141,416 (Direct) |
View |
| 2024-02-08 Tax Withholding |
2024-02-12 7:25 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Taubert Jennifer L EVP, WW Chair, Pharmaceuticals |
1,913 | $156.33 | 141,416 (Direct) |
View |
| 2024-02-08 Exercise |
2024-02-12 7:25 pm |
2024-02-08 N/A |
JOHNSON & JOHNSON | JNJ | Taubert Jennifer L EVP, WW Chair, Pharmaceuticals |
63,136 | $0 | 141,416 (Direct) |
View |
| 2024-02-08 Tax Withholding |
2024-02-12 7:25 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Duato Joaquin CEO and Chairman of the Board |
2,269 | $156.33 | 309,197 (Direct) |
View |
| 2024-02-08 Exercise |
2024-02-12 7:25 pm |
2024-02-08 N/A |
JOHNSON & JOHNSON | JNJ | Duato Joaquin CEO and Chairman of the Board |
5,225 | $0 | 309,197 (Direct) |
View |
| 2024-02-08 Tax Withholding |
2024-02-12 7:25 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Wengel Kathryn E EVP, Chief TO and Risk Officer |
1,009 | $156.33 | 67,241 (Direct) |
View |
| 2024-02-08 Exercise |
2024-02-12 7:25 pm |
2024-02-08 N/A |
JOHNSON & JOHNSON | JNJ | Wengel Kathryn E EVP, Chief TO and Risk Officer |
1,971 | $0 | 67,241 (Direct) |
View |
| 2024-02-08 Tax Withholding |
2024-02-12 7:25 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Wolk Joseph J Exec VP, CFO |
1,047 | $156.33 | 54,912 (Direct) |
View |
| 2024-02-08 Exercise |
2024-02-12 7:25 pm |
2024-02-08 N/A |
JOHNSON & JOHNSON | JNJ | Wolk Joseph J Exec VP, CFO |
3,686 | $0 | 54,912 (Direct) |
View |
| 2024-02-08 Tax Withholding |
2024-02-12 7:24 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Forminard Elizabeth Executive VP, General Counsel |
363 | $156.33 | 6,100 (Direct) |
View |
| 2024-02-08 Exercise |
2024-02-12 7:24 pm |
2024-02-08 N/A |
JOHNSON & JOHNSON | JNJ | Forminard Elizabeth Executive VP, General Counsel |
979 | $0 | 6,100 (Direct) |
View |
| 2024-02-08 Tax Withholding |
2024-02-12 7:24 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Swanson James D. See Remarks |
554 | $156.33 | 10,557 (Direct) |
View |
| 2024-02-08 Exercise |
2024-02-12 7:24 pm |
2024-02-08 N/A |
JOHNSON & JOHNSON | JNJ | Swanson James D. See Remarks |
1,868 | $0 | 10,557 (Direct) |
View |
| 2024-02-08 Tax Withholding |
2024-02-12 7:24 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Schmid Timothy EVP, WW Chair, MedTech |
1,001 | $156.33 | 10,688 (Direct) |
View |
| 2024-02-08 Exercise |
2024-02-12 7:24 pm |
2024-02-08 2024-02-08 |
JOHNSON & JOHNSON | JNJ | Schmid Timothy EVP, WW Chair, MedTech |
1,964 | $0 | 10,688 (Direct) |
View |
| 2024-02-08 Tax Withholding |
2024-02-12 7:24 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Fasolo Peter Exec VP, Chief HR Officer |
781 | $156.33 | 103,684 (Direct) |
View |
| 2024-02-08 Exercise |
2024-02-12 7:24 pm |
2024-02-08 N/A |
JOHNSON & JOHNSON | JNJ | Fasolo Peter Exec VP, Chief HR Officer |
2,135 | $0 | 103,684 (Direct) |
View |
| 2024-02-08 Tax Withholding |
2024-02-12 7:24 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Hait William See Remarks |
1,113 | $156.33 | 36,443 (Direct) |
View |
| 2024-02-08 Exercise |
2024-02-12 7:24 pm |
2024-02-08 N/A |
JOHNSON & JOHNSON | JNJ | Hait William See Remarks |
3,059 | $0 | 36,443 (Direct) |
View |
| 2024-02-08 Tax Withholding |
2024-02-12 7:24 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Broadhurst Vanessa EVP, Global Corp Affairs |
703 | $156.33 | 20,380 (Direct) |
View |
| 2024-02-08 Exercise |
2024-02-12 7:24 pm |
2024-02-08 N/A |
JOHNSON & JOHNSON | JNJ | Broadhurst Vanessa EVP, Global Corp Affairs |
1,880 | $0 | 20,380 (Direct) |
View |
| 2024-02-08 Tax Withholding |
2024-02-12 7:24 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Decker Robert J VP Corporate Controller |
215 | $156.33 | 18,088 (Direct) |
View |
| 2024-02-08 Exercise |
2024-02-12 7:24 pm |
2024-02-08 N/A |
JOHNSON & JOHNSON | JNJ | Decker Robert J VP Corporate Controller |
655 | $0 | 18,088 (Direct) |
View |
Ownership(A) |
2024-02-12 4:19 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Hait William See Remarks |
0 | $0 | 15,996 (Direct) |
View |
| 2023-12-05 Option Award |
2023-12-07 5:17 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | HEWSON MARILLYN A Director |
228 | $159.01 | 8,490 (Direct) |
View |
Ownership |
2023-11-02 4:36 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Schmid Timothy EVP, WW Chair, MedTech |
0 | $0 | 137,389 (Direct) |
View |
| 2023-09-07 Option Award |
2023-09-11 4:36 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | HEWSON MARILLYN A Director |
229 | $158.63 | 8,201 (Direct) |
View |
| 2023-08-23 Other |
2023-08-25 4:53 pm |
N/A N/A |
Kenvue Inc. | KVUE | JOHNSON & JOHNSON 10% Owner |
1,533,830,450 | $0 | 1,716,160,000 (Direct) |
View |
| 2023-07-26 Exercise |
2023-07-27 5:52 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Hait William See Remarks |
14,698 | $90.44 | 87,747 (Direct) |
View |
| 2023-07-26 Exercise |
2023-07-27 5:52 pm |
2017-02-11 2024-02-09 |
JOHNSON & JOHNSON | JNJ | Hait William See Remarks |
14,698 | $0 | 87,747 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-08 4:10 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | HEWSON MARILLYN A Director |
230 | $157.52 | 7,913 (Direct) |
View |
| 2023-05-24 Gift |
2023-05-25 4:52 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Wolk Joseph J Exec VP, CFO |
55 | $0 | 52,345 (Direct) |
View |
Ownership(A) |
2023-05-10 4:18 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Johnson Paula A Director |
0 | $0 | 102 (Indirect) |
View |
Ownership |
2023-05-03 4:16 pm |
N/A N/A |
Kenvue Inc. | KVUE | JOHNSON & JOHNSON 10% Owner |
0 | $0 | 1,716,160,000 (Direct) |
View |
| 2023-05-01 Option Award |
2023-05-02 5:21 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | REED JOHN C EVP, Pharmaceuticals R&D |
75,765 | $0 | 75,765 (Direct) |
View |
| 2023-04-27 Option Award |
2023-05-02 5:21 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | West Nadja Director |
1,194 | $0 | 3,599 (Direct) |
View |
| 2023-04-27 Option Award |
2023-05-02 5:21 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | WEINBERGER MARK A Director |
1,194 | $0 | 7,516 (Direct) |
View |
| 2023-04-27 Option Award |
2023-05-02 5:21 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | MULCAHY ANNE M Director |
1,194 | $0 | 19,494 (Direct) |
View |
| 2023-04-27 Option Award |
2023-05-02 5:21 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Johnson Paula A Director |
1,430 | $0 | 1,430 (Direct) |
View |
| 2023-04-27 Option Award |
2023-05-02 5:21 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | HEWSON MARILLYN A Director |
1,194 | $0 | 7,625 (Direct) |
View |
| 2023-04-27 Option Award |
2023-05-02 5:21 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | McClellan Mark B. Director |
1,194 | $0 | 15,997 (Direct) |
View |
| 2023-04-27 Option Award |
2023-05-02 5:21 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Joly Hubert Director |
1,194 | $0 | 4,929 (Direct) |
View |
| 2023-04-27 Option Award |
2023-05-02 5:21 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Doudna Jennifer A Director |
1,194 | $0 | 6,499 (Direct) |
View |
| 2023-04-27 Option Award |
2023-05-02 5:21 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Beckerle Mary C Director |
1,194 | $0 | 11,897 (Direct) |
View |
| 2023-04-27 Option Award |
2023-05-02 5:20 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | DAVIS D SCOTT Director |
1,194 | $0 | 13,799 (Direct) |
View |